Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society
Gespeichert in:
| Veröffentlicht in: | Neurology 2005-01, Vol.64 (1), p.172 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | 172 |
| container_title | Neurology |
| container_volume | 64 |
| creator | Panayiotopoulos, C P Benbadis, S R Covanis, A Dulac, O Duncan, J S Eeg-Olofsson, O Ferrie, C D Grünewald, R A Kasteleijn-Nolst Trenité, D G A Koutroumanidis, M Martinovic, Z Newton, R W Parker, A P J Salas-Puig, J Sander, J W Shorvon, S Watanabe, K Whitehouse, W P Youroukos, S |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_15645539</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15645539</sourcerecordid><originalsourceid>FETCH-pubmed_primary_156455393</originalsourceid><addsrcrecordid>eNqFkF1LwzAUhqsgdn78BTl_YLCttrLdFanojSDthXcjTU_XSPNBcoL035tlHeiVV4ecPDx531wmi3W-KZZFtvlMkxvnvlarsHjaXifpOi8e8zzbLi7Squ8FZ3wCpjogPaJlrRgFTaB7oAFB4Xe4I4FGjGhIcOisPzh42wFZZCRR0ZE9clo5JDiRbtqBRaMtnU3NEOQGfXC4-FyDfFB61IcJSufQueiqfcu1lIIIMWIfnsVANYUTs537i8z2UqINTRSUnHUoY_539Pbkj-1-U9UcEmrNBdJ0l1z1bHR4P8_b5OGlap5fl8a3Eru9sUIyO-3PX5f9C_wAWrqAhQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Panayiotopoulos, C P ; Benbadis, S R ; Covanis, A ; Dulac, O ; Duncan, J S ; Eeg-Olofsson, O ; Ferrie, C D ; Grünewald, R A ; Kasteleijn-Nolst Trenité, D G A ; Koutroumanidis, M ; Martinovic, Z ; Newton, R W ; Parker, A P J ; Salas-Puig, J ; Sander, J W ; Shorvon, S ; Watanabe, K ; Whitehouse, W P ; Youroukos, S</creator><creatorcontrib>Panayiotopoulos, C P ; Benbadis, S R ; Covanis, A ; Dulac, O ; Duncan, J S ; Eeg-Olofsson, O ; Ferrie, C D ; Grünewald, R A ; Kasteleijn-Nolst Trenité, D G A ; Koutroumanidis, M ; Martinovic, Z ; Newton, R W ; Parker, A P J ; Salas-Puig, J ; Sander, J W ; Shorvon, S ; Watanabe, K ; Whitehouse, W P ; Youroukos, S</creatorcontrib><identifier>EISSN: 1526-632X</identifier><identifier>PMID: 15645539</identifier><language>eng</language><publisher>United States</publisher><subject>Anticonvulsants - therapeutic use ; Diagnosis, Differential ; Epilepsy - diagnosis ; Health Planning Guidelines ; Humans ; Seizures - diagnosis</subject><ispartof>Neurology, 2005-01, Vol.64 (1), p.172</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15645539$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Panayiotopoulos, C P</creatorcontrib><creatorcontrib>Benbadis, S R</creatorcontrib><creatorcontrib>Covanis, A</creatorcontrib><creatorcontrib>Dulac, O</creatorcontrib><creatorcontrib>Duncan, J S</creatorcontrib><creatorcontrib>Eeg-Olofsson, O</creatorcontrib><creatorcontrib>Ferrie, C D</creatorcontrib><creatorcontrib>Grünewald, R A</creatorcontrib><creatorcontrib>Kasteleijn-Nolst Trenité, D G A</creatorcontrib><creatorcontrib>Koutroumanidis, M</creatorcontrib><creatorcontrib>Martinovic, Z</creatorcontrib><creatorcontrib>Newton, R W</creatorcontrib><creatorcontrib>Parker, A P J</creatorcontrib><creatorcontrib>Salas-Puig, J</creatorcontrib><creatorcontrib>Sander, J W</creatorcontrib><creatorcontrib>Shorvon, S</creatorcontrib><creatorcontrib>Watanabe, K</creatorcontrib><creatorcontrib>Whitehouse, W P</creatorcontrib><creatorcontrib>Youroukos, S</creatorcontrib><title>Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society</title><title>Neurology</title><addtitle>Neurology</addtitle><subject>Anticonvulsants - therapeutic use</subject><subject>Diagnosis, Differential</subject><subject>Epilepsy - diagnosis</subject><subject>Health Planning Guidelines</subject><subject>Humans</subject><subject>Seizures - diagnosis</subject><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1LwzAUhqsgdn78BTl_YLCttrLdFanojSDthXcjTU_XSPNBcoL035tlHeiVV4ecPDx531wmi3W-KZZFtvlMkxvnvlarsHjaXifpOi8e8zzbLi7Squ8FZ3wCpjogPaJlrRgFTaB7oAFB4Xe4I4FGjGhIcOisPzh42wFZZCRR0ZE9clo5JDiRbtqBRaMtnU3NEOQGfXC4-FyDfFB61IcJSufQueiqfcu1lIIIMWIfnsVANYUTs537i8z2UqINTRSUnHUoY_539Pbkj-1-U9UcEmrNBdJ0l1z1bHR4P8_b5OGlap5fl8a3Eru9sUIyO-3PX5f9C_wAWrqAhQ</recordid><startdate>20050111</startdate><enddate>20050111</enddate><creator>Panayiotopoulos, C P</creator><creator>Benbadis, S R</creator><creator>Covanis, A</creator><creator>Dulac, O</creator><creator>Duncan, J S</creator><creator>Eeg-Olofsson, O</creator><creator>Ferrie, C D</creator><creator>Grünewald, R A</creator><creator>Kasteleijn-Nolst Trenité, D G A</creator><creator>Koutroumanidis, M</creator><creator>Martinovic, Z</creator><creator>Newton, R W</creator><creator>Parker, A P J</creator><creator>Salas-Puig, J</creator><creator>Sander, J W</creator><creator>Shorvon, S</creator><creator>Watanabe, K</creator><creator>Whitehouse, W P</creator><creator>Youroukos, S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20050111</creationdate><title>Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society</title><author>Panayiotopoulos, C P ; Benbadis, S R ; Covanis, A ; Dulac, O ; Duncan, J S ; Eeg-Olofsson, O ; Ferrie, C D ; Grünewald, R A ; Kasteleijn-Nolst Trenité, D G A ; Koutroumanidis, M ; Martinovic, Z ; Newton, R W ; Parker, A P J ; Salas-Puig, J ; Sander, J W ; Shorvon, S ; Watanabe, K ; Whitehouse, W P ; Youroukos, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_156455393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anticonvulsants - therapeutic use</topic><topic>Diagnosis, Differential</topic><topic>Epilepsy - diagnosis</topic><topic>Health Planning Guidelines</topic><topic>Humans</topic><topic>Seizures - diagnosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Panayiotopoulos, C P</creatorcontrib><creatorcontrib>Benbadis, S R</creatorcontrib><creatorcontrib>Covanis, A</creatorcontrib><creatorcontrib>Dulac, O</creatorcontrib><creatorcontrib>Duncan, J S</creatorcontrib><creatorcontrib>Eeg-Olofsson, O</creatorcontrib><creatorcontrib>Ferrie, C D</creatorcontrib><creatorcontrib>Grünewald, R A</creatorcontrib><creatorcontrib>Kasteleijn-Nolst Trenité, D G A</creatorcontrib><creatorcontrib>Koutroumanidis, M</creatorcontrib><creatorcontrib>Martinovic, Z</creatorcontrib><creatorcontrib>Newton, R W</creatorcontrib><creatorcontrib>Parker, A P J</creatorcontrib><creatorcontrib>Salas-Puig, J</creatorcontrib><creatorcontrib>Sander, J W</creatorcontrib><creatorcontrib>Shorvon, S</creatorcontrib><creatorcontrib>Watanabe, K</creatorcontrib><creatorcontrib>Whitehouse, W P</creatorcontrib><creatorcontrib>Youroukos, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Panayiotopoulos, C P</au><au>Benbadis, S R</au><au>Covanis, A</au><au>Dulac, O</au><au>Duncan, J S</au><au>Eeg-Olofsson, O</au><au>Ferrie, C D</au><au>Grünewald, R A</au><au>Kasteleijn-Nolst Trenité, D G A</au><au>Koutroumanidis, M</au><au>Martinovic, Z</au><au>Newton, R W</au><au>Parker, A P J</au><au>Salas-Puig, J</au><au>Sander, J W</au><au>Shorvon, S</au><au>Watanabe, K</au><au>Whitehouse, W P</au><au>Youroukos, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society</atitle><jtitle>Neurology</jtitle><addtitle>Neurology</addtitle><date>2005-01-11</date><risdate>2005</risdate><volume>64</volume><issue>1</issue><spage>172</spage><pages>172-</pages><eissn>1526-632X</eissn><cop>United States</cop><pmid>15645539</pmid></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1526-632X |
| ispartof | Neurology, 2005-01, Vol.64 (1), p.172 |
| issn | 1526-632X |
| language | eng |
| recordid | cdi_pubmed_primary_15645539 |
| source | MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection |
| subjects | Anticonvulsants - therapeutic use Diagnosis, Differential Epilepsy - diagnosis Health Planning Guidelines Humans Seizures - diagnosis |
| title | Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A32%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20tolerability%20of%20the%20new%20antiepileptic%20drugs%20I:%20treatment%20of%20new%20onset%20epilepsy:%20report%20of%20the%20Therapeutics%20and%20Technology%20Assessment%20Subcommittee%20and%20Quality%20Standards%20Subcommittee%20of%20the%20American%20Academy%20of%20Neurology%20and%20the%20American%20Epilepsy%20Society&rft.jtitle=Neurology&rft.au=Panayiotopoulos,%20C%20P&rft.date=2005-01-11&rft.volume=64&rft.issue=1&rft.spage=172&rft.pages=172-&rft.eissn=1526-632X&rft_id=info:doi/&rft_dat=%3Cpubmed%3E15645539%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15645539&rfr_iscdi=true |